Ventas, Inc. (NYSE:VTR) Receives $99.11 Average Target Price from Analysts

Shares of Ventas, Inc. (NYSE:VTR) have been given an average rating of “Moderate Buy” by the seventeen brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $99.3889.

VTR has been the topic of several research reports. Barclays boosted their price target on Ventas from $99.00 to $102.00 and gave the stock an “equal weight” rating in a report on Monday, August 31st. Mizuho lifted their target price on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Jefferies Financial Group assumed coverage on shares of Ventas in a report on Tuesday, September 15th. They set a “buy” rating and a $102.00 target price on the stock. Wells Fargo & Company upped their price target on shares of Ventas from $96.00 to $104.00 and gave the company an “overweight” rating in a research report on Tuesday, September 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $100.00 price target on shares of Ventas in a report on Tuesday, June 16th.

Hedge Funds Weigh In On Ventas

Hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in Ventas during the 2nd quarter valued at approximately $4,953,439,000. Capital World Investors bought a new position in Ventas during the 4th quarter worth approximately $594,116,000. Norges Bank acquired a new position in shares of Ventas in the 4th quarter worth approximately $474,571,000. Legal & General Group Plc acquired a new position in shares of Ventas in the 2nd quarter worth approximately $501,850,000. Finally, Deutsche Bank AG bought a new stake in shares of Ventas in the 2nd quarter valued at $451,822,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Stock Performance

Shares of Ventas stock opened at $86.92 on Friday. Ventas has a fifty-two week low of $66.63 and a fifty-two week high of $101.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The firm has a market capitalization of $44.59 billion, a P/E ratio of 160.96, a P/E/G ratio of 3.38 and a beta of 0.70. The company’s 50 day moving average price is $92.37 and its two-hundred day moving average price is $88.04.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the business earned $0.87 earnings per share. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. On average, equities analysts forecast that Ventas will post 3.89 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.08 annualized dividend and a yield of 2.4%. Ventas’s payout ratio is presently 385.19%.

Ventas Company Profile

Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.

The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.

Ventas serves major healthcare and life science markets in the United States and Canada.